Cortical spreading depression (CSD), based on its similarities with peri-infarct depolarization, is an ideal model for investigating transformation from the ischemic penumbra to infarct core. However, the underlying mechanisms remain unclear. To our knowledge, this is the first study to use a middle cerebral artery occlusion ischemic-reperfusion (I/R) injury model to determine whether AMP-activated protein kinase (AMPK)-dependent autophagy contributes to the neuroprotection of CSD preconditioning in rat cortex. In this study, we topically applied a pledget soaked in 1 mol/L KCl solution on rat cortex for 2 h to elicite CSD or 1 mol/L NaCl solution as a control. The results demonstrated that CSD preconditioning significantly decreased the infarct volume, neurological deficits and neuronal apoptosis in the cortical penumbra of middle cerebral artery occlusion rats, which was inhibited by the ) levels induced by CSD. The neuroprotection of CSD is likely a result of AMPKmediated autophagy activity and autophagy-induced neuronal cells apoptosis inhibition. These novel findings support a central role for AMPK and autophagy in CSD-induced ischemic tolerance. AMPK-mediated autophagy may represent a new target for stroke.
Ischemic stroke is the third leading cause of disability and death worldwide, which currently lacks effective therapy. Therefore, seeking the means and mechanisms to stimulate the endogenous and pluripotent protection in acute brain injury is crucial. Preconditioning is considered as a powerful method for inducing endogenous protection, also called ischemic tolerance. First proposed by Kitagawa et al. (1990) , it has attracted rapidly the interest of neuroscientists in the hope of exploring new preventative and therapeutical targets. Cortical spreading depression (CSD) is a well-studied phenomenon and is characterized by slowly propagating and self-sustaining waves of a sizable population of neuronal/astrocytic depolarization and metabolic changes, followed by a period of quiescent neuronal and electroencephalographic (ECoG) activity (Leao 1947) . The ECoG change may occur in both apparently normal tissues and metabolically compromised tissues. Experimental induction of CSD is accomplished with electrical stimulation, needling of the cerebral cortex or super-fusion of an isotonic or more concentrated potassium chloride (KCl) solution. Recent clinical studies indicated that CSD is involved in the pathophysiology of migraine with aura (Hadjikhani et al. 2001) , amnesia (Maggioni et al. 2011) , stroke , traumatic brain injury (Fabricius et al. 2006) , and subarachnoid hemorrhage (Dreier et al. 2009 ). Previous studies have demonstrated that preconditioning the brain with CSD induced a substantial degree of ischemic tolerance to subsequent fatal ischemic exposure (Kawahara et al. 1995; Taga et al. 1997) . Meanwhile, compared with other preconditioning methods, CSD is more suitable for investigating the mechanism of endogenous neuroprotection because of its similarities with peri-infarct depolarization which occurs spontaneously in the boundary zone following focal cerebral ischemia and has been demonstrated to be involved in the conversion of the ischemic penumbra to the infarct core. Both CSD and peri-infarct depolarization are characterized by abrupt, near-complete sustained depolarization, the collapse of ion homeostasis, the release of neurotransmitters and other molecules from cellular compartments, and propagate at a similar rate (Somjen 2001; Dreier 2011) . To date, preconditioning with CSD has been assessed in both in vivo and in vitro models. However, the mechanism that underlies CSD is not fully understood.
Autophagy is a key catabolic process that degrades misfolded proteins and clears excess or damaged organelles by isolating them into double-membrane structures and fusing them with lysosomes. Autophagy plays an important role in maintaining the balance between the degradation, synthesis and recycling of cellular components (Levine and Klionsky 2004; Klionsky 2007) . Despite in depth studies of autophagy, the role of enhanced autophagy still remains controversial. Several studies have demonstrated that the activation of autophagy following stroke onset exacerbated ischemic neuronal injury (Baehrecke 2005; Codogno and Meijer 2005) . In contrast, other studies suggested that the pre-activation of autophagy remarkably enhanced the resistance against ischemic injury, as it facilitated cellular energy production, down-regulated endoplasmic reticulum stress and prevented neuronal apoptosis during subsequent fatal ischemic exposure (Papadakis et al. 2013; Xia et al. 2013) .
Recently, accumulating evidence has indicated that autophagy may participate in the mechanism underpinning ischemic tolerance, which has been demonstrated via preconditioning with ischemia (Xia et al. 2013; Gao et al. 2015) , anesthesia (Qiao et al. 2013 ) and hyperbaric oxygen (Yan et al. 2011) . However, it remains controversial and inconclusive as to the effects of autophagy in the pathogenesis of ischemic tolerance.
AMP-activated protein kinase (AMPK) is a Serine/Threonine kinase which are activated via phosphorylation. AMPK is a primary sensor of the cellular energy reserve because its level increases when the AMP/ATP ratio increases (Viggiano et al. 2014) . AMPK is also an important factor involved in neuroprotection. Abundant evidence indicates that AMPK can be activated by ischemic preconditioning and exerts beneficial effects (Kim et al. 2011; Xie et al. 2015) .
Autophagy has been proposed as a downstream target of AMPK (Meijer and Codogno 2014) . The activation of autophagy mediated by AMPK represents a potential protective mechanism in the early stage of brain injury (Gao et al. 2012) . Interestingly, Viggiano et al. (2014) reported that CSD could activate AMPK in the central nervous system. However, whether autophagy and AMPK participate in the development of CSD-induced ischemic tolerance has not been investigated.
On the basis of these findings, we hypothesize that autophagy and AMPK are participating in the mediation of the increased resistance to ischemic damage induced by CSD. We tested this hypothesis in a rat model of focal cerebral ischemia induced by middle cerebral artery occlusion (MCAO) lasting 2 h followed by reperfusion of 12 h. The hypothesis revealed that autophagy may be a new therapeutic target for cerebral ischemic/reperfusion injury. We postulate that it might be an effective treatment for ischemic stroke by the use of stimulation of autophagy.
Materials and methods

Animals
All animal experiments were approved and governed by the Medical Ethics Committee of The First Affiliated Hospital of Jilin University (No. 2014-265) , and in compliance with the National Regulation of China for Care and Use of Laboratory Animals. The reporting of animal protocols was in accordance with the ARRIVE guidelines (Animal Research: Reporting in Vivo Experiments). All efforts were made to minimize animals suffering and the number of animals used.
Male Wistar rats (3 months old, 300-350 g in body weight, Grade II) were obtained from The Basic Medical Science, Jilin University Animal Center. The 191 animals were individually housed in standard animal rooms (temperature 20-24°C, relative humidity 45-55%) on a 12 : 12 h light-dark cycle. Food and water were available ad libitum. The overall condition including weight, coat, feces, and activity were monitored closely. After surgery, the animals were kept in a clean, warm and quiet environment. At the end, the rats were decapitated following a lethal dose of 10% chloral hydrate (0.35 mg/kg) anesthesia.
Experimental design and drugs
The 191 rats were randomized (having first been numbered using yellow dye, then allocated according to the random number table) to one of ten groups involving two surgical procedures: a control group with sham operation+MCAO and experimental groups with CSD preconditioning+MCAO; the detailed protocol was illustrated by Fig. 1 . The two major experimental drugs were 3-methyladenine (3-MA, an autophagy inhibitor) and Compound C (CC, an AMPK inhibitor), which were both purchased from Selleckchem Inc. (Houston, TX, USA) and administrated 30 min before CSD. The 3-MA was first dissolved in dimethyl sulfoxide (Bioss, Beijing, China) at a stock concentration of 10 mmol/mL and subsequently diluted in saline to a working concentration of 0.02 mmol/mL. CC was dissolved in saline to a final concentration of 20 mg/mL. The selection of the dosage (20 mg/kg) and administration route (intraperitoneal injection, i.p) for CC was based on Manwani and McCullough (2013) . The dosage (200 nmol) of 3-MA was selected according to Sheng et al. (2010) . To minimize the side effects of 3-MA (Heckmann et al. 2013) , and to avoid additional lesions, an intracerebroventricular injection (i.c.v.) in the right hemisphere was used. During the procedure, the operation of CSD and MCAO were, respectively, performed by two experimenters who were blind to the allocation of the animals. The statistical analysis including infarct volume calculation, neurological deficit scores assessment, positive cells counting, gel electrophoresis banding quantization was performed by investigators other than the experimenters to avoid bias. Sample size was selected based on data from pilot experiments in our group and calculated by GPower software (3.1.9.2; Franz Faul, University Kiel, Germany) using yet provided power and hypothetical effect size as estimated to detect a 35% difference between the anticipated means of groups assuming a standard deviation of 20% to estimate number of animals. For our power calculation, we assumed an equal standard deviation in each group. With a = 0.05 and a power of 80%, we needed a minimum of five rats per group. So we employed 5-6 rats in each group for western blot, immunofluorescence, transmission electronmicroscopy, and apotosis analysis, 8-9 rats in each group for infarct volume calculation. Animals were excluded if: (i) they were in a persistent coma or dead (Neurobehavioral test score 5), or suffering from epilepsy intra-operatively or post-operatively; (ii) the procedure failed or there was persistent bleeding or subarachnoid hemorrhage during the MCAO procedure; (iii) dramatic weight loss more than 20% or deterioration in body condition after surgery. A total of 191 rats were allocated detailed as below: group 1 (n = 29), group 2 (n = 14), group 3 (n = 15), group 4 (n = 14), group 5 (n = 29), group 6 (n = 14), group 7 (n = 19), group 8 (n = 19), group 9 (n = 17), group 10 (n = 16). For animals receiving the multiple surgical interventions, in total five animals were excluded during MCAO procedure, detail as group 1 (n = 1), group 2 (n = 1), group 5 (n = 1), group 6 (n = 1), group 8 (n = 1).
CSD induction CSD was induced as described by Viggiano et al. (2014) (Matsushima et al. 1998) . After i.p injection of 10% chloral hydrate (0.35 mg/kg) and 2% lidocaine as the topical anesthetics and Fig. 1 Experimental groups and protocol. Cortical spreading depression (CSD) was performed by placing 1 mol/L potassium chloride (KCl) on the cortical surface for 2 h. Transient ischemic/reperfusion model was created by middle cerebral artery occlusion (MCAO) for 2 h followed by 12 h of reperfusion. Ten groups were studied. Control group (group1, Ctr): 1 mol/L sodium chloride (NaCl) was applied to the cortical surface 12 h before induction of MCAO. In the 2nd to the 6th groups, MCAO was induced at 0 (CSD0 h), 3 (CSD3 h), 6 (CSD6 h), 12 (CSD12 h) and 24 (CSD24 h) hours after CSD. In the 7th to 10th groups, the rats were given the autophagy inhibitor 3-methyladenine (3-MA, i.c.v., 200 nmol) and Vehicle (Veh, i.c.v.) of equal volume, the AMPK inhibitor Compound C (i.p, 20 mg/kg) and Vehicle (Veh, i.p) of equal volume, 30 min before CSD. MCAO was induced 12 h after CSD.
analgetic, body temperature was maintained at normal values (36.5-37.5°C) throughout the experiment using a thermostatic heating pad (NOMOY PET Inc. Guangzhou, China). After the head was mounted in a stereotaxic frame (Rivard Inc., Shenzhen, China), the skull was exposed by a longitudinal midline skin incision and two small burr holes were carefully made under a surgical microscope (Olympus, Tokyo, Japan) to prevent breaking the duramater. One 2 mm diameter burr hole was drilled on the left side 3 mm anterior to and 3 mm laterally from bregma for topical application of KCl. A second 2 mm burr hole was drilled 4 mm posterior to and 4 mm laterally from bregma for placement of a Ag/ AgCl electrode (1 mm diameter) to monitor ECoG. CSD was elicited by the placement of a pledget soaked in 1 mol/L KCl in the first hole directly in contact with the duramater. The 1 mol/L sodium chloride (NaCl), which does not elicit CSD, was applied as a control operation. A fresh pledget was reapplied every 15 min. ECoG were recorded using two Ag/AgCl electrodes: one electrode was applied on the surface of the exposed KCl-treated parietal cortex and the reference electrode was fixed subcutaneously in the neck skin. The electrodes were connected to Bio Amplifier (FE132; AD Instruments, Dunedin, Australia) and Powerlab Biological Signal Acquisition System (T402PB; AD Instruments). To stop CSD, the burr hole was rinsed with saline three times. The burr holes were filled with dental cement (Hygedent Inc., Peking, China) following removal of the pledget. All wounds were subsequently closed and sterilized. All data were continuously recorded via a computer equipped with a multiple monitoring system (Labchart 7; Jilin University, Changchun, China).
MCAO (ischemic/reperfusion)
The MCAO model was induced by filament as previously described with several modifications . Briefly, after anesthetization, the left external and internal carotid arteries (ECA and ICA, respectively) were exposed through a midline neck incision. The ECA was cut between double ligations at the distal portion. A 0.26 mm silicone-tipped filament which was purchased from Xinong Inc. (2636; Beijing, China), was inserted into the ICA via the ECA stump and advanced in the ICA approximately 19-22 mm from the carotid bifurcation. Following the obstruction of the common carotid artery by a microvascular clip, the suture around the ECA stump was tightened and the incision was closed. During reperfusion, the filament was unplugged to recover the blood flow of the MCA. The animals were re-anesthetized 2 h later to remove the suture. Body temperature was maintained at normal values (36.5-37.5°C) throughout the operation until they revived. Following reperfusion, the rats were maintained in the cage with dry, warm padding and kept the room temperature at 20-24°C, allowed free access to food and water. Twelve hours later, the rats were deeply anaesthetized via an i.p injection of 10% chloral hydrate (0.35 mg/kg), followed by decapitation.
Western blot analysis
At indicated time points (0, 3, 6, 12, 24 h) after CSD and 12 h after NaCl control, rat cortex was immediately frozen in liquid nitrogen. We managed to identify the penumbra referring to (Ashwal et al. 1998) . The whole penumbra cortex was homogenized in lysis buffer (ristocetin-induced platelet agglutination 1 mL, 100 mm/L phenylmethanesulfonyl fluoride 20 lL, 1 mm/L natrium fluoride 50 lL, 100 mm/L sodium vanadate 10 lL), centrifuged at 12 000 g for 20 min at 4°C and the supernatant was collected. The insoluble material was removed by centrifugation for an additional 15 min at 14 000 g at 4°C. The protein concentration of the supernatant was determined using a bicinchoninic acid Protein-Assay-Kit (P0010; Beyotime, Shanghai, China). Loading buffer (Tris-HCl 0.666 g, Tris-base 0.682 g, sodium dodecyl sulfate 0.8 g, EDTA 0.006 g, Glycerol 4 g, 1% blue G250 0.75 mL, ultrapure water 10 mL, 1% Phenol Red 0.25 mL) was added to the samples. The protein concentration was adjusted using (SDS buffer, ultrapure water, 500 mm/L DL-dithiothreitol) to ensure consistency and denatured at 90°C for 10 min. The samples were subsequently separated on 12% SDS-polyacrylamide gel electrophoresis in running buffer (0.3% Tris-base, 1.44% glycine, 0.1% SDS) at 60 V for 1 h, followed by 120 V for 2-3 h. Following electrophoresis, the proteins were transferred onto a polyvinylidene fluoride membrane (Millipore Corporation, Bedford, MA, USA) in transfer buffer (Tris-base 3.03 g, glycine 14.4 g, methanol 200 mL, ultra-pure water 800 mL) for 1 h at 200 V. The membranes were blocked in 5% non-fat dry milk for 2 h and subsequently incubated overnight at 4°C with rabbit-monoclonal-antibody against AMP-activated protein kinase (AMPKa) (1 : 500, 5831; Cell Signal, Boston, MA, USA), rabbitmonoclonal-antibody against phosphor-AMPK: p-AMPKa (Thr   172   ) (1 : 500, 2325; Cell Signal), rabbit-polyclonal-antibody against LC3-II (1 : 1000, ab63817; Abcam, Cambridge, MA, USA), rabbitpolyclonal-antibody against Beclin-1 (1 : 1000, ab55878; Abcam), rabbit-polyclonal-antibody against P62 (1 : 500, ab91526; Abcam), rabbit-polyclonal-antibody against ULK1 (1 : 300, bs-3602R; Bioss), rabbit-polyclonal-antibody against p-P70S6K (Thr   389   ) (1 : 500, ab2571; Abcam) and a loading control antibody b-actin (1 : 500, bs0061R; Bioss), washed in Phosphate-buffered Saline with tween-20 (PBS-T) three times for 5 min each time. The blots were subsequently incubated with secondary anti-rabbit-IgG-horseradish peroxidase goat antibody (1 : 1000, BA1054; Boster, Wuhan, China) for 1 h at 37°C. The membranes were imaged using an Electro-Chemi-Luminescence-Kit (Boster) with a Microscopic Digital Imaging System (Olympus). The band intensities were analyzed using Quantity One software 4.6.2 (Bio-Rad Laboratories, Hercules, CA, USA) and normalized to b-actin.
Immunofluorescence
At indicated time points, the rats were anesthetized with 10% chloral hydrate (0.35 mg/kg), followed by decapitation. The whole brains were rapidly removed and placed in pre-cold isopentane (Beijing Chemical Factory, Beijing, China). The brains were placed in À80°C refrigerator for quick-freezing for 5 min. The cortex was subsequently dissected with a coronal cut anterior to the optic chiasm, embedded in optimum cutting temperature compound (Sakura Finetek Inc., Torance, CA, USA) and stored in the À80°C refrigerator. The brains were subsequently sliced at a thickness of 10 lM using a frozen slicer (Leica, Nussloch, Germany), fixed in 4% cold paraformaldehyde (PFA) for 10 min and washed with PBS three times for 5 min per time. The slides were blocked with a blocking solution, which contained 10% normal goat serum and 1% Triton-100 in PBS at 37°C for 1 h and then incubated with the rabbit-polyclonal-antibody against LC3-II (1 : 200, ab63817; Abcam), mouse-monoclonal-antibody against Glial fibrillary acidic protein (1 : 200, ab10062; Abcam) and mouse-monoclonal-antibody against NeuN (1 : 200, ab104224 ; Abcam) at 4°C overnight in a humidified box. The sections were incubated in the primary antibodies against LC3-II, NeuN or GFAP mixed like cocktails, respectively, and subsequently rinsed with PBS, then incubated with goat-anti-rabbit IgG (Alexa Fluor 647, 1 : 200, ab150091; Abcam) and goat-anti-mouse IgG (Alexa Fluor 488, 1 : 200, ab150113; Abcam), respectively, for 1 h at 37°C in a humidified container. The sections were then washed three times for 5 min each time and incubated with 0.5 mg/mL 4,6-diamidino-2-phenylindole (Bioss Inc.). A solution without primary antibody was used as the negative control. The brain sections were analyzed with a laser scanning confocal microscope (Olympus Inc.).
Transmission electronmicroscopy
A transmission electron microscopy (TEM) examination was performed as previously described (Nakatani and Beitner 1992) . Briefly, the brain tissue was sliced into sections, fixed in 4% glutaraldehyde, washed in PBS for 10-45 min and immersed in 1% osmium tetroxide for 2 h at 4°C. The sections were rinsed with distilled water three times for 15 min, dehydrated in graded ethanol and embedded in epoxy resin. The sections were subsequently cut into ultrathin sections (60-70 nm) with an ultramicrotome (EMUC7; Leica), stained with uranyl acetate and lead citrate, and then analyzed with a transmission electron microscope (H-7650; Hitachi, Hong Kong, China).
2,3,5-Triphenyltetrazolium chloride staining and infarct size measurement 2,3,5-triphenyltetrazolium chloride (TTC) staining was performed as described by (Takahashi et al. 2012) to evaluate the infarct volume. The rats were killed under deep anesthesia followed by decapitation at 12 h after reperfusion. The brains were rapidly removed and sectioned coronally at 2 mm intervals using a rat brain matrix (Alto Company, Cumberland, USA). Each slice was immersed in 2% TTC solution (Sigma Aldrich, St. Louis, USA) for 30 min at 37°C and then fixed with 4% PFA. Normal tissue displays red meanwhile the infarct zone stains white. The sections were photographed using a digital camera (Olympus). The infarct volume was determined using an Image Pro-Plus 5.1 analysis system (Media Cybernetics Inc., Rockville, MD, USA). To avoid the influence of edema, the infarct volume was calculated as follows:
P n i (right hemisphere area À left uninfarcted area) 9 d (i represents section i, n represents the number of sections, d represents section thickness) (Swanson et al. 1990; Gao et al. 2008) . All lesion volume calculations were performed by one researcher to reduce variability.
Terminal-deoxynucleotidyltransferase-mediated nick end labeling Twelve hours after MCAO, the rats were anesthetized with 10% chloral hydrate. The brains were cut into 10 lM frozen slices and fixed with 4% PFA. Transferase dUTP nick end labeling (TUNEL) staining was performed using a Cell-Apoptosis-Detection-Kit (Roche Inc., Basel, Switzerland) according to the manufacturer's instructions. Cells labeled with green fluorescence in the peri-infarct region represented TUNEL-positive cells. Cell counting was performed on three randomly selected, non-overlapping fields in the peri-infarct region of the cerebral cortex per slide. Designation of these core and penumbral regions was based on studies that defined the core to include subcortical structures, primarily the lateral caudoputamen and overlying cortex, whereas the adjacent ventrolateral cortex was designated as penumbra (Barber and Wechsler 2010; Heiss 2011) . The numbers of TUNEL-positive cells obtained from every field were summed and normalized to the total cell numbers, obtained via 4,6-diamidino-2-phenylindole staining.
Neurobehavioral testing
Neurobehavioral tests were performed at 12 h after MCAO using the Longa' scores (Longa et al. 1989) . A score of 0 indicated no neurological deficits, 1 indicated a failure to fully extend the right forepaw, 2 indicated circling to the right, 3 indicated falling to the right, and 4 indicated the animal did not walk spontaneously and had a depressed level of consciousness, 5 indicated dead which were eliminated from the experiments.
Statistical analysis
All assessments were analyzed by investigators blinded to the experimental group. Statistical analysis was performed using SPSS 18.0 Software (SAS Institute Inc., Cary, NC, USA). All data are expressed as mean AE standard deviation. For numerical data, oneway analysis of variance (ANOVA) followed by Bonferroni post tests were used to compare multiple groups and non-parametric t-test was used to compare two groups. For ranked data, such as neurological deficits, Kruskal-Wallis test were used followed by Wilcoxon test. A p value of less than 0.05 was considered significant.
Results
ECoG demonstration during preconditioning procedure The application of 1 mol/L KCl induced a remarkable decrease in the amplitude of the ipsilateral cortex from 117.25 AE 3.51 lV to 78.36 AE 3.46 lV (p < 0.01) that lasted for the entire duration of CSD (Fig. 2a) , whereas there was no significant change in amplitude with the application of 1 mol/L NaCl in Ctr group, from 115.93 AE 4.12 to 109.58 AE 3.94 (p > 0.05) (Fig. 2b) . The ECoG depression occurred within several minutes after KCl application; however, the frequency changes were not significant. It should be noticed that, neither the administration of 3-MA nor CC itself, influenced the amplitude, frequency and the latency from KCl application to the occurrence of ECoG depression.
CSD reduced the infarct volume and ameliorated the neurological deficits after MCAO with protective effects prevented by autophagy inhibitor 3-MA The infarct volume measured at 12 h after MCAO decreased with time and reached a lowest value in CSD12 h group. Compared with Ctr group, it was significantly reduced from 113.7 AE 31.7 to 69.2 AE 16.1 mm 3 (p < 0.05) (Fig. 3a and  c) . The same trend was observed in the neurological scores (Fig. 3e ) which peaked in CSD12 h group (p < 0.05). Pretreatment with 3-MA 30 min before CSD in 3-MA+CSD group significantly attenuated the neuroprotective effect compared with Veh+CSD group, indicated by infarct volume (p < 0.05) and neurological deficit scores (p < 0.05) (Fig. 3b, d and f) .
CSD preconditioning activated AMPK-mTOR signaling and induced autophagy Western blot analysis indicated that the molecular markers of autophagy in the cerebral cortex showed significant changes in CSD groups compared with Ctr group. As shown in Fig. 4(a) and (b), the protein level of LC3-II over control increased in a time related manner, which included a significant increase at 0 h and peaked at 12 h, then showed a slight decrease at 24 h after CSD (p < 0.01). Another autophagy marker, Beclin-1, exhibited similar changes: significantly increased from 6 h, peaked at 12 h and began to decrease at 24 h (p < 0.01). P62, which represents the characteristic substrate for autophagic degradation, decreased with time, and bottomed at 12 h (p < 0.001). Pretreatment with 3-MA significantly inhibited CSD-induced autophagy demonstrated by the levels of LC3-II (p < 0.05) and P62 (p < 0.01) (Fig. 4c and d) . Furthermore, these findings were verified via immunofluorescence analysis using an increased selectivity anti-LC3-II antibody (Fig. 4e) . The results demonstrated that increased LC3-II immunepositive cells in the ipsilateral cortex in CSD12 h group compared with the Ctr group (p < 0.05). TEM was also used to validate the increasing of autophagosomes with a doublemembrane structure (Fig. 4f) .
Furthermore, the molecular changes in AMPK-mTOR pathway were also verified by Western blot. The ratio of p-AMPK (Thr 172 )/AMPK, as well as the protein level of p-P70S6K (Thr 389 ), a downstream signaling molecule of the mTOR signal pathway and its phosphorylation represents mTOR activation, were assessed. The p-AMPK (Thr 172 )/ AMPK ratio was up-regulated in a monophasic way (Fig. 5) : it significantly increased from 0 h, peaked at 12 h and started to decrease at 24 h (p < 0.001). The protein level of p-P70S6K (Thr 389 ) was down-regulated(p < 0.001). These findings indicated the up-regulation of p-AMPK (Thr 172 )/ AMPK activity within 24 h and mTOR pathway inhibition after CSD.
Inhibition of AMPK by compound C abolished CSD-induced autophagy in the brain
To confirm the relationship between AMPK and CSDinduced autophagy, rats were administered a single dose of CC (20 mg/kg, i.p.) 30 min prior to CSD. The protein levels of LC3-II (p < 0.05), P62 (p < 0.01), p-P70S6K (Thr 389 ) (p < 0.05) and ULK1 (p < 0.01), p-AMPK(Thr 172 )/AMPK (p < 0.05) were analyzed via Western blot 12 h after CSD. CC significantly attenuated the CSD-induced increase in LC3-II (Fig. 6a ) and this finding was further confirmed by immunofluorescence analysis (Fig. 6b) and TEM examination (Fig. 6c) . Furthermore, the reduction in the P62 level induced by CSD was also reversed by CC pretreatment. The ratio of p-AMPK(Thr 172 )/AMPK was decreased after CC administration. The AMPK-mTOR pathway maker protein p-P70S6K(Thr 389 ) in CC+CSD group was significantly increased compared with that in Veh+CSD group. Another signaling protein ULK1 showed an opposite trend compared with p-P70S6K(Thr 389 ) (Fig. 6a) .
Increased LC3-II immuno-positive cells after CSD occur selectively in rat cortical neurons Double immunofluorescence for LC3-II and markers for neuron (NeuN), and astrocytes (GFAP), were performed to determine the distribution of LC3-II in CSD12 h group in cortex of the preconditioned hemispheres (Fig. 7) . The results demonstrated that LC3-II was predominantly co-expressed with NeuN. The percentage of LC3-II-NeuN co-expressed cells was 87.2%, whereas the percentage of LC3-II-GFAP co-expressed cells was 2.89% (p < 0.01). No positive immuno-staining was identified in the control sections without primary antibody.
CSD preconditioning may decrease neuronal cells apoptosis in the peri-infarct cortex of MCAO model via the augmentation of autophagy TUNEL staining was utilized to demonstrate apoptotic cells. The percentage of TUNEL-positive cells (in red) in CSD group was significantly ameliorated in the penumbra compared with the Ctr group ( Fig. 8a and b, 21 .4 AE 4.8% vs. 30.2 AE 4.4%, respectively, of the total cell numbers (p < 0.05). After pretreatment with the autophagy inhibiter 3-MA, the CSD-induced decrease in apoptosis was inhibited, illustrated by Fig. 8(c) 
Discussion
The major finding of this study is that CSD preconditioning induced autophagy via an AMPK-dependent pathway, which significantly decreased the infarct volume and neurological deficits caused by I/R injury in a MCAO rat model. To the best of our knowledge, this is the first study to link CSD preconditioning and AMPK-induced autophagy. First, we conducted TTC staining and determined the neurological deficits score, to confirm the protective effect of CSD. As shown in Fig. 3 , the neuroprotective effect is the strongest at 12 h after CSD. Based on this finding, 12 h was selected as the preconditioning time point. Abundant studies support our results, which indicated a decrease in the lesion size when CSD was induced several hours to 1 day prior to the ischemic events (Kobayashi et al. 1995; Yanamoto et al. 2004) . With regards to the duration of CSD-induced tolerance, it is not consistent across different studies, induction methods, animal models and KCl concentrations and range from several minutes (Gniel and Martin 2013) to several days (Wiggins et al. 2003; Richter et al. 2008) prior to an ischemic event. Thus, there are at least two temporal profiles of neuronal tolerance: rapid or acute tolerance (CSD induces protection within minutes; Kariko et al. 2004 ) and delayed tolerance (protection occurs several hours to several days after CSD; Horiguchi et al. 2006) . In this study, after 12 h of CSD, the neuroprotective effect peaked which was confirmed via molecular studies. These findings indicate that the CSD preconditioning effect lasts a minimum of 12 h. Furthermore, various methods have been used in the literature to induce CSD, such as mechanical trauma, pinprick, electrical stimulation, and the application of KCl (Somjen 2001) . Among these, KCl is the most commonly used. The KCl concentration ranged from 0.5 to 5 mol/L. A high concentration of KCl (5 mol/L) has been reported to cause tiny cortical lesions, which may influence the results (Muramatsu et al. 2004) . In contrast, low concentrations of KCl may not be sufficient to impose a significant burden on ionic homeostasis in the extracellular environment and thus to induce CSD. The concentration (1 mol/L) in the present experiment was chosen referring to (Viggiano et al. 2014) . Meanwhile, the stimulation time differs from several minutes to several hours, even up to 48 h (prolonged CSD) (Yanamoto et al. 2004) . This study used 2 h as the stimulating time based on (Horiguchi et al. 2006) . Second, the current findings demonstrate that CSD exerts its neuroprotective effects by increasing autophagy. Autophagy is a conserved process in eukaryotic cells that degrades damaged organelles and recycles cellular constituents. Autophagy dysfunction is involved in the pathogenesis of diverse diseases (Levine and Kroemer 2008; Doria et al. 2013) . Furthermore, an increasing number of investigators have begun to examine the relevance between the neuroprotective effects of various pretreatment methods, such as ischemic preconditioning (Park et al. 2009; Gao et al. 2015) , hyperbaric oxygen preconditioning and remote limb ischemic post-conditioning (Qi et al. 2012) , as well as other preconditioning methods (Sala-Mercado et al. 2010), with autophagy. However, the role of autophagy in these preconditioning methods may be different. Autophagy activation has been suggested to contribute to the protective effect (Williams et al. 2013; Jiang et al. 2014) , whereas other investigators have argued that the inhibition of autophagy exerts the protective effect. For example, (Gao et al. 2012 ) used a permanent MCAO in combination with a transient common carotid artery occlusion model demonstrating that inhibition of the autophagy pathway plays a major role. Indeed, the role of autophagy in cell death/survival remains debated and complicated. (Matsui et al. 2008) have demonstrated that in the case of myocardial ischemia injury, autophagy led to cell survival, whereas the reperfusion injury caused cell death. Our study provides the first preliminary evidence that pre-activated autophagy via CSD preconditioning exerts beneficial effects in a rat model of MCAO (I/ R). We suggest that the neuroprotective effect of CSDactivated autophagy is likely a result of the autophagic elimination of damaged mitochondria and endoplasmic reticulum fragments. This area represents our next target to explore in the future.
Third, to further investigate the mechanism of CSDactivated autophagy, we analyzed the effects of CSD on AMPK, which is a primary sensor of cellular energy and maintains cellular energy. The p-AMPK/AMPK ratio (Fig. 5) , not the protein level of AMPK or p-AMPK, increased with time compared with the control; it peaked at 12 h and started to decrease at 24 h, which is consist with the results of the autophagy markers. These findings are supported by ) and (Viggiano et al. 2014) , which indicated that the p-AMPK/AMPK ratio is a regulator of autophagy. When pretreated with CC, the changes in LC3-II, P62 and ULK1, using combined methods of Western blot, Immunofluorescence and TEM, indicated the inhibition of autophagy and highlighted the relationship between AMPK and autophagy Takagi et al. 2007) . Indeed, AMPK is important in cell survival and energy conservation, both in vivo (Carloni et al. 2010) and in vitro (Gabryel et al. 2014 ) studies have demonstrated that AMPK activation enhances survivability under reduced energy supply, protects cells from oxygen glucose deprivation and glutamate excitotoxicity . Recently, increasing evidence has suggested that autophagy is a downstream target of AMPK in various organs (Adhami et al. 2006) . The activation of autophagy mediated by AMPK represents a potential protective mechanism in the early stage of brain injury (Williams et al. 2013; Wang et al. 2014) . In preconditioning methods, AMPK-activated autophagy has been demonstrated to be a protective mediator of ischemic metabolic adaptation (Venna et al. 2012; Gabryel et al. 2014) . However, no previous study has investigated CSD and autophagy. Our research is the first investigation to link CSD with autophagy.
AMPK activates autophagy via multiple signaling pathways. Several lines of evidence suggest that AMPK activation enhanced autophagy via the inhibition of mTOR, a conserved Ser/Thr kinase that, in most studies, reverse regulates autophagy (Ding et al. 2007) . In this study, we analyzed the effects of CSD on p-P70S6K (Thr 389 ), which is a downstream signaling molecule of mTOR pathway activation. The current findings demonstrated that the phosphorylation of p-P70S6K (Thr 389 ) was decreased 12 h after CSD. Furthermore, recent studies have indicated that AMPK enhanced autophagy via the direct phosphorylation of ULK1 (Kim et al. 2011 ). The precise pathway by which AMPK-activated autophagy in the brain should be further investigated in future studies.
Fourth, the autophagy marker LC3-II has been demonstrated to be predominant in neuronal cells (marked by NeuN), but rarely in astrocyte cells (marked by GFAP) using immunofluorescence double staining (Fig. 7) . The current findings are consistent with previous studies. (Carloni et al. 2010) reported that in an ischemic model, the increase in LC3-II and Beclin-1 only occurred in the neurons of the cortex and hippocampal CA1 neurons, but not in astrocytes or microglia. (Lum et al. 2005; Konishi et al. 2012) reported that preconditioning stimuli induced autophagy in cortical neurons. Interestingly, (Viggiano et al. 2014 ) demonstrated that in a CSD preconditioning model similar to the present work in time points, AMPK was mainly expressed in neuronal cells in the cortex. However, the role of other cells except neurons in neuroprotection remains ambiguous and several researchers have presented conflicting results. ( Papadakis et al. 2013) and (Adhami et al. 2006) demonstrated that ischemia-induced autophagy also occurred in astrocytes and vascular endothelial cells. This contradiction may be explained by the different animal species, ischemic time windows and durations in the different experimental design. The most important is the different preconditioning models. In this study, we explored the distribution of LC3-II in different cell types in CSD preconditioning model. Although, astrocytes have also been reported in CSD initiation in some aspects (McGrail et al. 1991) , it is still extensively believed that neurons are functionally predominant in CSD initiation and propagation (Herreras and Somjen 1993; Canals et al. 2005) and astrocytes are passive to neurons in depolarization as well as cells swelling and the interstitial space shrinks (Zhou et al. 2010) , which implicate the mechanism of CSD-induced tolerance may be largely depended on cortical neurons. However, in other preconditioning methods, it is more complicated because there is abundant evidence which indicate the mutual effects between different cell types (Hoshi et al. 2016; McDonough and Weinstein 2016) .
Fifth, we preliminarily investigated the relationship between autophagy and apoptosis of neuronal cells in CSD-induced ischemic tolerance, since we have previously demonstrated that increased LC3-II immuno-positive cells after CSD occur selectively in rat cortical neurons. Autophagy has long been linked to a form of cell death referred to as type II cell death (Das et al. 2012) , whereas apoptosis is considered type I cell death (Maiuri et al. 2010) . We propose that CSD preconditioning may exert neuroprotective effects via AMPK-activated autophagy and apoptosis inhibition. Nevertheless, the molecular biological mechanism requires further investigation. The relationship between autophagy and apoptosis is complicated. Some scholars suggested that, under certain conditions, autophagy and apoptosis are mutually reinforcing (Carloni et al. 2008; Twig et al. 2008; Wirawan et al. 2010) . Beclin-1 is a key component of the autophagy initiation machinery (Carloni et al. 2010 ) and a pro-apoptotic molecule that leads to apoptosis. In contrast, other scholars demonstrated that autophagy and apoptosis develop in a mutually exclusive manner (Lum et al. 2005; Konishi et al. 2012) . Substantial crosstalk exists between apoptosis and autophagy. This paradox reflects the complexity of the relationship between autophagy and apoptosis, both of which are affected by the duration of ischemia and differences in the experimental models of ischemia (Papadakis et al. 2013) . Our study supports the hypothesis that autophagy exerts neuroprotective effects via a reduction in apoptotic neuronal cells death in the ischemic penumbra. To the best of our knowledge, there is substantial evidence that ischemic preconditioning exerts an influence on apoptosis, whereas no similar results regarding the impact of CSD on apoptosis during ischemia and reperfusion have been reported. Similar studies in other preconditioning models confirm our findings (Ding et al. 2007; Xia et al. 2013) .
Furthermore, CSD preconditioning, as a widely acknowledged animal model to induce ischemic tolerance, just like other conditioning methods such as ischemic preconditioning, is also confronted with the challenge of 'bench to bed side'. Despite a wealth of preclinical, experimental animal data demonstrating clear neuroprotective benefits with these treatment strategies, their translation into clinical therapy has been frustrated. Apparently, we could not directly impose the experimental method on human cortex. However, the protective effects of CSD preconditioning could offer potential insights into mechanisms of ischemic tolerance because of the resemblance between CSD wave and periinfarct depolarizations and the vasomotor effects CSD wave exerts on the cerebral vasculature (Gorji 2001) . In this research, the selection of CSD preconditioning model was primarily based on the relationship between expansion of cerebral infarcts and the mechanism of CSD initiation and propagation. CSD is more suitable for investigating the pathological and physiological evolution of ischemic penumbra and therefore seeking new therapeutic targets in neurovascular disease treatment. Recently, the clinical impact of CSD has become more and more obvious. Accumulating evidence indicates that CSD underlies the migraine aura in human and that similar waves promote development of secondary neurological deterioration in stroke, trauma, and hemorrhage (Eikermann-Haerter et al. 2013) . The occurrence of spreading depolarization/depression events and their ECoG features in the cerebral cortex in patients during cerebral surgery, represent a novel pathophysiological mechanism in this setting.
Finally, despite the novelty of the current findings, there are several limitations that must be considered in the interpretation of the results. First, autophagy is a doubleedged sword and there is no unified understanding with regards to the role of autophagy in ischemic/reperfusion injury and the molecule pathway by which autophagy has been activated. In the present article, we used 3-MA and CC to investigate the neuroprotective effect of CSD-induced autophagy and the corresponding AMPK-mTOR-autophagy pathway. However, the exact effect of autophagy and AMPK independent of CSD preconditioning has not been addressed in this study. It is necessary to consummate this research in our next research. Second, we used a rat transient I2 h/R12 h injury model rather than a permanent ischemic model which may exhibit different results. The selection of ischemic/ reperfusion injury model was based on the overall protocol of our research group and other literature reports. However, the histological outcome of stroke at a longer time point has not been included which may exhibit different results. Furthermore, 3-MA is not a specific inhibitor of autophagy compared with the small interfering RNA (siRNA) and the RNA silencing technology which block the autophagy flux in genetic levels. Meanwhile, the injection of 3-MA and CC may have potential side-effects that may exert some influence on the results.
In summary, our findings suggest that CSD preconditioning is protective against I/R injury via the activation of AMPK-mediated autophagy and the inhibition of apoptosis. Future studies that address the role of CSD preconditioning should focus on the autophagic and apoptotic gene variations. Accordingly, the investigation of autophagy activation during CSD preconditioning is necessary to better understand the evolution of the infarct penumbra and to determine the corresponding treatment.
